Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scientist Home Future HealthSHFH +11.11%8 PS Ratio is 277.78 as of Aug. 23, 2026, which is 131% above its 10-year median of 120.00. GuruFocus rates SHFH with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Scientist Home Future Health ranks worse than 99.7% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Scientist Home Future Health's share price is $5.00.
Scientist Home Future Health's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $0.02. Hence, Scientist Home Future Health's PS Ratio for today is 277.78.
Warning Sign:
Scientist Home Future Health Ltd stock PS Ratio (=277.78) is close to 1-year high of 277.78.
The historical rank and industry rank for Scientist Home Future Health's PS Ratio or its related term are showing as below:
SHFH'
s PS Ratio Range Over the Past 10 Years
Min: 105.56 Med: 120 Max: 277.78
Current: 277.78
During the past 2 years, Scientist Home Future Health's highest PS Ratio was 277.78. The lowest was 105.56. And the median was 120.00.
SHFH's PS Ratio is ranked worse than 99.7% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.55
vs SHFH: 277.78
Scientist Home Future Health (OTCPK:SHFH) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Scientist Home Future Health PS Ratio Related Terms
Scientist Home Future Health PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Scientist Home Future Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scientist Home Future Health PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Scientist Home Future Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where Scientist Home Future Health's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Scientist Home Future Health's Share Price of today is $5.00. Scientist Home Future Health's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Scientist Home Future Health (SHFH) has a PS Ratio of 277.78 as of Aug. 23, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Scientist Home Future Health and its competitors. This is 131% above median its historical median of 120.00. Over the past decade, Scientist Home Future Health's PS Ratio has ranged from 105.56 to 277.78. According to the industry distribution chart, Scientist Home Future Health ranks #657 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 99.7%.
Is Scientist Home Future Health's PS Ratio too high?
Scientist Home Future Health's current PS Ratio of 277.78 is 131% above median its 10-year median of 120.00. Over the past 10 years, this metric has ranged from a low of 105.56 to a high of 277.78. The Healthcare Providers & Services industry median PS Ratio is 1.55. Scientist Home Future Health's value of 277.78 is 17821.3% above this industry median. Based on the distribution chart, Scientist Home Future Health ranks #657 out of 659 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Scientist Home Future Health has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Scientist Home Future Health's PS Ratio compare to BHIC and PETS?
According to the Healthcare Providers & Services industry distribution chart, Scientist Home Future Health ranks #657 out of 659 companies for PS Ratio. This places Scientist Home Future Health in the lower half of its industry. The industry median PS Ratio is 1.55. Scientist Home Future Health's value of 277.78 is 17821.3% above this benchmark. Historically, Scientist Home Future Health's own PS Ratio has ranged from 105.56 to 277.78 over the past decade. While the company's 10-year median is 120.00 vs. the industry median of 1.55, Scientist Home Future Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.55, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scientist Home Future Health's current PS Ratio of 277.78 is 17821.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Scientist Home Future Health and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scientist Home Future Health's current PS Ratio is 277.78, which is 131% above median its own 10-year median of 120.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scientist Home Future Health stock overvalued right now?
Scientist Home Future Health (SHFH) has a current PS Ratio of 277.78. The current PS Ratio is 277.78, which is 131% above median its 10-year median of 120.00 and 17821.3% above the Healthcare Providers & Services industry median of 1.55. Scientist Home Future Health's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Scientist Home Future Health (SHFH), the current PS Ratio is 277.78 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Scientist Home Future Health Ltd, through its subsidiaries, engages in the retail trading of health supplements and topical creams and provision of physical check-up services in Hong Kong. It focuses on developing sustainable rehabilitation solutions, particularly for degenerative diseases, ensuring that the products not only address current symptoms but also support future, long-term health and recovery. The company has two reportable segments based on business unit, retail trading and service business. The majority of revenue is derived from the Retail Trading segment, which derives revenue from customers by providing health supplements and topical creams. It has two reportable segments based on geographical location: Hong Kong and Non-Hong Kong; key revenue derives from Hong Kong.
8GF Score
Get the complete analysis for SHFH
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHFH has been successfully added to your 
